🇺🇸 tolterodine SR, overactive bladder in United States

tolterodine SR, overactive bladder (tolterodine SR, overactive bladder) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

tolterodine SR, overactive bladder in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is tolterodine SR, overactive bladder approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for tolterodine SR, overactive bladder in United States?

Pfizer's Upjohn has merged with Mylan to form Viatris Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.